Word

INDALIFO

Status

Dead

Status Code

606

Status Date

Monday, March 4, 2024

Serial Number

97361995

Mark Type

4000

Filing Date

Wednesday, April 13, 2022

Published for Opposition

Tuesday, June 6, 2023

Abandoned Date

Monday, March 4, 2024

Trademark Owner History

Iovance Biotherapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations and biological preparations for the treatment of oncological and immune system related diseases and disorders; diagnostic preparations for medical use, namely, biological diagnostic preparations for medical use

44 Medical services; medical diagnostic services; medical treatment of cancer via the modification of cells; medical services, namely, medical services for the treatment of a wide range of diseases and medical conditions via the modification of cells; medical services in the field of immunotherapy treatments; medical diagnosis and treatment of immune system related diseases and disorders; medical services, namely, medical services for the diagnosis and treatment of a wide range of diseases and medical conditions; providing medical information relating to oncology and immunotherapy treatment; providing medical information; medical consultations

Trademark Events

Mar 4, 2024

Abandonment Notice E-Mailed - No Use Statement Filed

Mar 4, 2024

Abandonment - No Use Statement Filed

Aug 1, 2023

Noa E-Mailed - Sou Required From Applicant

Jun 6, 2023

Official Gazette Publication Confirmation E-Mailed

Jun 6, 2023

Published For Opposition

May 17, 2023

Notification Of Notice Of Publication E-Mailed

May 1, 2023

Approved For Pub - Principal Register

May 1, 2023

Examiner's Amendment Entered

May 1, 2023

Notification Of Examiners Amendment E-Mailed

May 1, 2023

Examiners Amendment E-Mailed

May 1, 2023

Examiners Amendment -Written

Apr 27, 2023

Teas/Email Correspondence Entered

Apr 26, 2023

Correspondence Received In Law Office

Apr 26, 2023

Teas Response To Office Action Received

Oct 26, 2022

Notification Of Non-Final Action E-Mailed

Oct 26, 2022

Non-Final Action E-Mailed

Oct 26, 2022

Non-Final Action Written

Oct 19, 2022

Assigned To Examiner

Apr 19, 2022

New Application Office Supplied Data Entered

Apr 16, 2022

New Application Entered